chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After vaccination patient started complaining of itchy throat.  She then stated she was dizzy and that there was a lump in her throat.  A few minutes after that she stated it was hard to swallow.  She also complained about tingling around her lips and had some swelling of her lips.  Pt was then given epinephrine and taken to the emergency room.
1 of 2 children vaxed from different lots who devel an inj site rxn described as redness, itching & welts surrounding site;welts also appeared on other places on the arm;no fever reported;Atarax prescribed-pt recovered
c/o hallucinations-spider and roaches crawling and fever hair coming out 4 hours post vaccination. C/O mild dizziness s/sx lasted approximately 4 hours. Client took vaccine on empty stomach. Next a.m. completely resolved.
headache, balance is off, tired, no energy - drink electrolyte water and stayed home from work
This spontaneous report was received from a pharmacy technician referring to multiple patients of unknown ages and genders. The patients' medical history or concurrent conditions were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (lot # L046884, expiration date 23-NOV-2017) dosage information, route and anatomical site of vaccination were not informed, for prophylaxis. Concomitant therapies included sterile diluent (manufacturer unknown) which was stored in correct range. No adverse effects were reported. There was no product quality complaint involved. It was also reported that the vaccines experienced temperatures from 9° C to 25° C. The time frame was 6.5 hours. There was no previous temperature excursion. The call was because of a "data logger".  Additional information is not expected, since the physician contact details were not provided.
I now have tinnitus, which never had before.   I have weakening in my arms and restricted reach and movement of my arms.
tested positive for COVID19/symptoms lasted 5-6 days; tested positive for COVID19/symptoms lasted 5-6 days; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 07Apr2021 (Batch/Lot number was not reported) as single for COVID-19 immunisation. Medical history included exposure to COVID-19 from an unknown date. The patient's concomitant medications were not reported. The patient had his first dose of bnt162b2 on 07Apr2021. He had exposure and two weeks later, on 21Apr2021, he tested positive for COVID19. Furthermore, he mentioned that he has not showed any symptoms as of the moment and all symptoms lasted 5-6 days. Outcome of the events was reported as unknown.  Information on the batch/lot number has been requested.
Swollen arm; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm) and HEADACHE (Severe headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 003CB1A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jun-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm) and HEADACHE (Severe headache). At the time of the report, PERIPHERAL SWELLING (Swollen arm) and HEADACHE (Severe headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No medical history reported No concomitant medication provided.
Received Pfizer vaccines on 3/17/21, 4/7/21 Tested positive for COVID-19 by PCR on 5/24/21. Onset date of symptoms 5/20/21 w/ cough, congestion, sore throat Underlying  large cell lymphoma
TEMPERATURE EXCURSION OF VACCINE; ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a pharmacist concerned a 49 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, expiry: 02-OCT-2021) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-MAY-2021, the patient experienced temperature excursion of vaccine. On 26-MAY-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the temperature excursion of vaccine and administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210916455, 20210916553, 20210916312, 20210916910, 20210915661, 20210916697, 20210915719, 20210917226, 20210916808, 20210915646, 20210913164, 20210916715, 20210917163, 20210916907, 20210916768, 20210917515, 20210915852, 20210916965, 20210916959, 20210916658, 20210915623, 20210917500, 20210916300, 20210916584 and 20210916811.; Sender's Comments: V0; Medical assessment comment not required as per standard procedure as case assessed as non-serious.
pt recv vax; devel 4 large raised welts at inject site which were 4" in diam;itchy & painful;welts worsened;devel irregular hardened areas w/ 2 papules;tx w/ dph;
Heat; Itchiness; Pain; broke out in hives/irst noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs; A spontaneous report was received from a consumer of 38 years old female patient who experienced broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs, heat, itchiness and pain.   The patient's medical history was not provided.    Concomitant medications included Synthroid (levothyroxine sodium) at 100 milligram  once daily via unknown route for an unknown indication.   On 06-Feb-2021, prior to the onset of the events  the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly in the unknown anatomical location for prophylaxis of COVID-19 infection.   On 12-Feb-2021, the patient experienced broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs, and on 13-Feb-2021 experienced pain, heat, itchiness and pain.    Treatment information included Benadryl at an unknown dose and frequency via an unknown route for the events broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs, heat, itchiness and pain.   Action taken with mRNA-1273 in response to the events broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs, heat, itchiness and pain was unknown at the time of reporting.  The outcome of the events broke out in hives/first noticed it in the trunk, it was a burning sensation/It was moving from my ribs to my chest and inner arms and thighs was recovered on an unknown date and the outcome of the events heat, itchiness and pain was unknown at the time of reporting.
I had a subarachnoid hemorrhage on 4/30/21. It was suspected to be caused by a ruptured aneurysm.  I was previously healthy and have no personal nor family history of this. It is unknown whether or not it is associated with the vaccine.
They told me to come back in one month for the second dose. When; This case was reported by a consumer via interactive digital media and described the occurrence of drug prescribing error in a 18-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included Men B NVS (Bexsero) and meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device).   On an unknown date, the patient received the 2nd dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device and an unknown time after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced drug prescribing error. On an unknown date, the outcome of the drug prescribing error was unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: This case was reported by patient's parent. The patient had received Bexsero vaccine 2 months before her 18th birthday at her neighborhood and told to come back in one month for the second dose and when reporter returned a month later, the pharmacist said it was one dose of vaccine which led to drug prescribing error
Vaccine given on 1/28/21 at 10:25 am. Mild muscle aches began later on in day, more than 6 hours but less than 12 hours from administration. At around 3am on 1/29/21 severe chills, headache, and fever of 104.3 F began. Chills, fever, and headache continued throughout the next day. At 7am, fever reduced to 101.1 F. Tylenol was taken at 7am. At 10am fever remained and Ibuprofen was taken. Around 11am fever was reduced to 98 F. Tylenol and Ibuprofen continued to alternate every 3 hours. Temperature has been controlled with alternating therapy, although waves of chills and heat flashes remain. Headache was never reduced with therapy. In addition, adequate amount of water was taken throughout the day beginning at 7am on 1/29. Muscle aches subsided around 7am on 1/29.
On 1/30/01, noted slight redness at injection site that was red x 4-5 days. No streaking. No drainage. Swelling at injection site noted on 2/1/01. No drainage. Swelling x 2-5 days. Symptoms resolved on their own. No clinic follow-up.
fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Case number PHEH2015US026976, is a spontaneous report initially received from a nurse on 22 Dec 2015. This report refers to a 52 years old female patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501, expiry date: May 2016) into left deltoid on 06 Oct 2015. It was reported that FLUVIRIN administered to the patient had a temperature excursion of 34 degrees. The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day and the temperature was fine. It was a new refrigerator and there were no problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. Follow up information received via nurse on 26 Jan 2016: Reporter's comment updated.
Initial report was received 11 August 2010 with additional information received 16 August 2010 from a health care professional which involved a cluster of eight patients who tested positive for pertussis. Patient identifiers were provided for seven patients; two who had previously received ADACEL (captured in case number 2010-04349 and 2010-04350); and  three who had previously received an unspecified Tdap vaccine (captured in case number 2010-04352, 2010-04353 and 2010-04354), and two patients who had not received ADACEL, but had previously received a full DtaP vaccination series (captured in case numbers 2010-04351 (this case) and 2010-04376). At the time of the report, no information was available for the eighth unidentified patient. An 8-year-old male patient had received five previous injections of DtaP (manufacturers, lot numbers, routes and sites of administration not reported) and an unspecified amount of time later, he developed a break through case of pertussis and tested positive for pertussis. The patient had two 11-year-old twin siblings who experienced the same event. Outcome was not reported and no further information was provided at the time of the report. Documents held by sender: None.
Woke with Temp 103 F, chills, sweats, swollen R Arm.
About eight hours after receiving my second dose, I started to run a high fever around 104 degrees. About every hour and a half to two hours, my temperature would lower, but then shoot back up again. This lasted for about 16 hours. After that it hovered around 99 degrees. I also experienced extremely bad chills even though my house temperature was pretty warm.
continued and worsening L arm pain s/p J&J COVID-19 vaccine on 4/4. pt was seen in urgent care on 4/14 and 4/15 for L arm pain and swelling, w/ tingling down to hand/fingers
pt recv vax 5AUG98 & pt devel ITP on 25AUG98 felt to be secondary to MMR vax;
PT C/O OF ABDOMINAL RASH APPROX 2 DAYS FOLLOWING ADMINISTRATION OF VACCINE. PT STATES RASH COVERS ABDOMEN BUT IS UNSURE IF RELATED TO VACCINE OR IF IT IS JUST A FLARE OF HASHIMOTO'S SX. PT INSTRUCTED TO CHECK IN WITH MD OFFICE ON MONDAY OR TO SEEK URGENT CARE IF CONDITION WORSENS (SHORTNESS OF BREATH, WORSENING RASH WITH HIVES, ELEVATED FEVER).
Some soreness at the top of my left arm and both hands felt hot and stiff . I kept waking up and rubbing my hands as they felt very stiff.  If I touched my face with either hand they felt hot.  They were fine when I woke up but still a little stiff.
PATIENT PRESENTS TO CLINIC ON 8-16-23 COMPLAINING OF RIGHT UPPER ARM PAIN, SWELLING, AND WOUND FROM VACCINE SITE OF SHINGLES INJECTION THAT THE PHARMACIST INJECTED ON 8-14-23.  PATIENT DENIES ANY FEVER, DYSPNEA, CHEST PAIN, VOMITING, OR CHILLS. HTN/HLD/DMT2/ELEVATED LIVER ENZYMES/OBESE/GERD
Initial unsolicited report received from a Health care professional on 08-Mar-2018. This case involves a 16-year-old female patient, who was vaccinated once with 0.5 ml single booster dose of MENACTRA via intramuscular route (batch number - U5839AA, expiry date, site not reported) on 26-Feb-2018. Patient had no allergies and no medical history. Patient's concomitant medications were not reported. On an unknown date, following vaccination patient had stiff neck, back headache and a swollen tongue due to which mom took her to the urgent care on 28-Feb-2018. It was also reported they did not know what testing was performed in the urgent care of what the treatment plan at discharge. Patient also had MENACTRA at 11 to 12 years old and had no issues. Lab test and corrective treatment was not reported. Patient was recovered from the events as symptoms have all resolved at this point. Documents held by sender: none. Sender's Comments: Patient developed Stiff neck, tension headache and swollen tongue after vaccination. Time to onset is compatible with the role of vaccine. However additional information, including but not limited to, the patient's immunization history (i.e., previous immunizations and any adverse events following immunization), allergic history, medical history, previous similar episodes as well as allergy testing to identify the culprit allergen are needed to further assess this case. Moreover, as two vaccines were administered concomitantly, the role of each component cannot be assessed separately.
Patient states she became weak and felt like having heart palpitations and flushing.  Stated hands turned red.
Under arm swollen with node; Under arm swollen with node and a little painful; The patient received dose 1 and 2 of Moderna and dose 3 of BNT162b2; Dose received : 3; This is a spontaneous report from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 29Nov2021 at 19:00 (Lot number: unknown) at the age of 43 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Scleroderma" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Moderna covid-19 vaccine (DOSE 2, SINGLE, Lot number: UNKNOWN, Anatomical location: Left arm), administration date: 05May2021, when the patient was 42 years old, for COVID-19 immunisation and Moderna covid-19 vaccine (DOSE 1, SINGLE, Lot number: UNKNOWN, Anatomical location: Left arm), administration date: 05Apr2021, when the patient was 42 years old, for COVID-19 immunisation.  The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 29Nov2021 at 19:00, outcome "unknown", described as "The patient received dose 1 and 2 of Moderna and dose 3 of BNT162b2"; IMMUNISATION (non-serious) with onset 29Nov2021 at 19:00, outcome "unknown", described as "Dose received : 3"; LYMPHADENOPATHY (non-serious) with onset 01Dec2021, outcome "not recovered", described as "Under arm swollen with node"; AXILLARY PAIN (non-serious) with onset 01Dec2021, outcome "not recovered", described as "Under arm swollen with node and a little painful". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy and axillary pain.  Additional Information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The lot number for BNT162b2 was not provided and will be requested during follow up.
After 12 hours  from injection and continuing for 48 hours, fever and chills alternating, entire body aches and headache. After 24 hours swelling in arm pit if right arm occurred snd remains to date.
RECEIVED FLU SHOT ON 10/4/2011. C/O TINGLING IN LEFT ARM, STARTED ON 10/4/2011 LATE AFTERNOON. NO SWELLING AT INJECTION SITE, BUT BRUISED. TOOK ASA FOR "WEIRD FEELING IN ARM" AND RUBBED ICE ON AREA. 10/17/11 PT STILL C/O TINGLING IN ARM.
Patient explained that the day she received the vaccine and for 3 days after that below the site of injection (same areas towards the front of breasts) it was swollen and what she described as "goose eggs." She said it was red, heated, itch and sore. She said she didn't experience any fever but the reaction was uncomfortable. She is much better now and the reaction has subsided. She almost feels fine.
I am a breastfeeding mother (my baby was born 2022). I exclusively pump my breastmilk and feed my baby via bottle. I track the amount of breastmilk I pump on a daily basis.   The day after I received my COVID vaccine (2nd booster), my breastmilk supply started to drop precipitously. In the month prior to my COVID vaccine, I pumped an average of 47 oz of breastmilk daily, with a minimum of 44 oz. On day 4 after receiving my COVID vaccine, my breastmilk supply had dropped to 40 oz, which is the lowest amount of breastmilk I had ever pumped over the prior 7 months.   In response, on days 5-18 I pumped 1 extra hour per day to increase my breastmilk supply (I normally pump for 2 hours per day). My breastmilk supply returned to normal levels (about 47 oz daily) on day 11 and has remained stable to date.
Woke up at 4am went to pee and felt dizzy disoriented and almost as if hallucinating. Starting to lose balance and go in and out of consciousness for a few seconds, hitting walls in bathroom with face then exited  bathroom and fainted and was unconscious for 30ish seconds. Wife called 911 emt came blood pressure was low around 90/48. Went to PCP at 230pm later that day and blood pressure back to normal and no other issues found
30-45 seconds after MMR vaccine administered SQ in left deltoid SQ fatty tissue, patient slumped in chair, eyes halfclosed, upper and lower extremities started to jerk spasmodically, sonorous respirations heard, patient unresponsive to verbal command, decreased level of consciousness, biting tip of tongue. Reaction lasted approximately 30 seconds, then patient's limbs relaxed, eyes opened, and he became responsive. Amnesic to event, skin pale, and started have rigors/chills without feeling cold. 911 activated while vital signs obtained: BP 100/60, hr 46-53, pulse ox 96% on room air, respiratory rate 12-16, respirations easy and unlabored. Denies any difficulty breathing, denies any sensation of anxiety prior to or during vaccination. Denies dizziness or lightheadedness, nausea, or abdominal discomfort. Stated he felt like his heart rate sped up just prior to reaction, now no palpitations. After 5-7 minutes states his chest is feeling "tight", denies chest pain. Nurse practitioner prepares to administer EpiPen, patient reports that sensation of tightness has passed, paramedics arrive and assume care.  Epinepherine not adminstered.
Initial report received on 17 October 2012 from the Investigator participating in a post-marketing study under the reference number M5A16. A case of pertussis disease in a 22-month-old female subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received 3 doses of PENTACEL; lot number C3771AA received on 25 January 2011, lot number C3784AA received on 18 May 2011 and lot number C3801AA received on 22 June 2011 (routes and sites of administration not reported). The subject developed a cough on 01 August 2012, approximately 13 months after the last dose. Paroxysmal cough without a whoop began on 02 August 2012. The subject also experienced sleep disturbance (onset dates not reported). Laboratory testing included positive PCR on 03 August 2012. Chest x-ray findings were negative for pneumonia. Corrective treatment consisted of azithromycin starting on 03 August 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 20 August 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 19 days. According to the investigator, this case was epidemiologically linked to a laboratory confirmed case. Investigator causality assessment is not required as per protocol. Documents held by sender: None.